The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Pharmacogenomics of GPCR Drug Targets
Open accessAbstract
Natural genetic variation in the human genome is a cause of individual differences in responses to medications and is an underappreciated burden on public health. Although 108 G-protein-coupled receptors (GPCRs) are the targets of 475 (∼34%) Food and Drug Administration (FDA)-approved drugs and account for a global sales volume of over 180 billion US dollars annually, the prevalence of genetic variation among GPCRs targeted by drugs is unknown. By analyzing data from 68,496 individuals, we find that GPCRs targeted by drugs show genetic variation within functional regions such as drug- and effector-binding sites in the human population. We experimentally show that certain variants of μ-opioid and Cholecystokinin-A receptors could lead to altered or adverse drug response. By analyzing UK National Health Service drug prescription and sales data, we suggest that characterizing GPCR variants could increase prescription precision, improving patients' quality of life, and relieve the economic and societal burden due to variable drug responsiveness. VIDEO ABSTRACT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A global reference for human genetic variation
The 1000 Genomes Project Consortium, authors, C., Auton, A., Abecasis, G. R., Steering committee, Altshuler, D. M., Durbin, R. M., Abecasis, G. R., Bentley, D. R., Chakravarti, A., et al. (2015) · Nature · doi:10.1038/nature15393 · Cited by 18,247
Analysis of protein-coding genetic variation in 60,706 humans
Exome Aggregation Consortium, Lek, M., Karczewski, K. J., Minikel, E. V., Samocha, K. E., Banks, E., Fennell, T., O’Donnell-Luria, A. H., Ware, J. S., Hill, A. J., et al. (2016) · Nature · doi:10.1038/nature19057 · Cited by 9,587
SIFT: predicting amino acid changes that affect protein function
Ng, P. C. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg509 · Cited by 6,577
Predicting Functional Effect of Human Missense Mutations Using PolyPhen‐2
Adzhubei, I., Jordan, D. M., & Sunyaev, S. R. (2013) · Current Protocols in Human Genetics · doi:10.1002/0471142905.hg0720s76 · Cited by 3,705
PhosphoSitePlus, 2014: mutations, PTMs and recalibrations
Hornbeck, P. V., Zhang, B., Murray, B., Kornhauser, J. M., Latham, V., & Skrzypek, E. (2015) · Nucleic Acids Research · doi:10.1093/nar/gku1267 · Cited by 3,411
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Trends in GPCR drug discovery: new agents, targets and indications
Hauser, A. S., Attwood, M. M., Rask-Andersen, M., Schiöth, H. B., & Gloriam, D. E. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.178 · Cited by 2,627
Self-citationA comprehensive map of molecular drug targets
Santos, R., Ursu, O., Gaulton, A., Bento, A. P., Donadi, R. S., Bologa, C. G., Karlsson, A., Al-Lazikani, B., Hersey, A., Oprea, T. I., et al. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.230 · Cited by 2,427
Classification of Intrinsically Disordered Regions and Proteins
van der Lee, R., Buljan, M., Lang, B., Weatheritt, R. J., Daughdrill, G. W., Dunker, A. K., Fuxreiter, M., Gough, J., Gsponer, J., Jones, D. T., et al. (2014) · Chemical Reviews · doi:10.1021/cr400525m · Cited by 2,174
Self-citationDrugBank 4.0: shedding new light on drug metabolism
Law, V., Knox, C., Djoumbou, Y., Jewison, T., Guo, A. C., Liu, Y., Maciejewski, A., Arndt, D., Wilson, M., Neveu, V., et al. (2014) · Nucleic Acids Research · doi:10.1093/nar/gkt1068 · Cited by 1,993
Pharmacogenomics — Drug Disposition, Drug Targets, and Side Effects
Evans, W. E., & McLeod, H. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmra020526 · Cited by 1,769
Molecular signatures of G-protein-coupled receptors
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., & Babu, M. M. (2013) · Nature · doi:10.1038/nature11896 · Cited by 1,497
Self-citationSouthan, C., Sharman, J. L., Benson, H. E., Faccenda, E., Pawson, A. J., Alexander, S. P. H., Buneman, O. P., Davenport, A. P., McGrath, J. C., Peters, J. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1037 · Cited by 1,035
Pharmacogenomics in the clinic
Relling, M. V., & Evans, W. E. (2015) · Nature · doi:10.1038/nature15817 · Cited by 904
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
Kang, Y., Zhou, X. E., Gao, X., He, Y., Liu, W., Ishchenko, A., Barty, A., White, T. A., Yefanov, O., Han, G. W., et al. (2015) · Nature · doi:10.1038/nature14656 · Cited by 807
The BioMart community portal: an innovative alternative to large, centralized data repositories
Smedley, D., Haider, S., Durinck, S., Pandini, L., Provero, P., Allen, J., Arnaiz, O., Awedh, M. H., Baldock, R., Barbiera, G., et al. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv350 · Cited by 755
Structural Features for Functional Selectivity at Serotonin Receptors
Wacker, D., Wang, C., Katritch, V., Han, G. W., Huang, X.-P., Vardy, E., McCorvy, J. D., Jiang, Y., Chu, M., Siu, F. Y., et al. (2013) · Science · doi:10.1126/science.1232808 · Cited by 664
Management of Opioid Analgesic Overdose
Boyer, E. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1202561 · Cited by 605
Cryo-EM structure of the activated GLP-1 receptor in complex with a G protein
Zhang, Y., Sun, B., Feng, D., Hu, H., Chu, M., Qu, Q., Tarrasch, J. T., Li, S., Sun Kobilka, T., Kobilka, B. K., et al. (2017) · Nature · doi:10.1038/nature22394 · Cited by 576
How Ligands Illuminate GPCR Molecular Pharmacology
Wacker, D., Stevens, R. C., & Roth, B. L. (2017) · Cell · doi:10.1016/j.cell.2017.07.009 · Cited by 560 · cited 1×
“…sites, effector selectivity sites, receptor stability, and oligomerization (Congreve et al., 2017; Costa-Neto et al., 2016; Flock et al., 2015, 2017; Gahbauer Cell 172 , 41–54, January 11, 2018 43 and Bo¨ckmann, 2016; Katritch et al., 2014; Venkatakrishnan et al., 2013, 2016; Wacker et al., 2017).”
GPCRdb in 2018: adding GPCR structure models and ligands
Pándy-Szekeres, G., Munk, C., Tsonkov, T. M., Mordalski, S., Harpsøe, K., Hauser, A. S., Bojarski, A. J., & Gloriam, D. E. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1109 · Cited by 553
Self-citationEndophilin marks and controls a clathrin-independent endocytic pathway
Boucrot, E., Ferreira, A. P. A., Almeida-Souza, L., Debard, S., Vallis, Y., Howard, G., Bertot, L., Sauvonnet, N., & McMahon, H. T. (2015) · Nature · doi:10.1038/nature14067 · Cited by 542
Clinical and economic burden of adverse drug reactions
Sultana, J., Cutroneo, P., & Trifirò, G. (2013) · Journal of Pharmacology and Pharmacotherapeutics · doi:10.4103/0976-500x.120957 · Cited by 528
Allosteric sodium in class A GPCR signaling
Katritch, V., Fenalti, G., Abola, E. E., Roth, B. L., Cherezov, V., & Stevens, R. C. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.03.002 · Cited by 511
Open Targets: a platform for therapeutic target identification and validation
Koscielny, G., An, P., Carvalho-Silva, D., Cham, J. A., Fumis, L., Gasparyan, R., Hasan, S., Karamanis, N., Maguire, M., Papa, E., et al. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw1055 · Cited by 504
Generic GPCR residue numbers – aligning topology maps while minding the gaps
Isberg, V., de Graaf, C., Bortolato, A., Cherezov, V., Katritch, V., Marshall, F. H., Mordalski, S., Pin, J.-P., Stevens, R. C., Vriend, G., et al. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.11.001 · Cited by 492
Self-citationJubb, H. C., Higueruelo, A. P., Ochoa-Montaño, B., Pitt, W. R., Ascher, D. B., & Blundell, T. L. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.12.004 · Cited by 487
Cholecystokinin and Gastrin Receptors
Dufresne, M., Seva, C., & Fourmy, D. (2006) · Physiological Reviews · doi:10.1152/physrev.00014.2005 · Cited by 476
Action of Molecular Switches in GPCRs - Theoretical and Experimental Studies
Trzaskowski, B., Latek, D., Yuan, S., Ghoshdastider, U., Debinski, A., & Filipek, S. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799320556 · Cited by 469
Phase-plate cryo-EM structure of a class B GPCR–G-protein complex
Liang, Y.-L., Khoshouei, M., Radjainia, M., Zhang, Y., Glukhova, A., Tarrasch, J., Thal, D. M., Furness, S. G. B., Christopoulos, G., Coudrat, T., et al. (2017) · Nature · doi:10.1038/nature22327 · Cited by 462
Liggett, S. B., Mialet-Perez, J., Thaneemit-Chen, S., Weber, S. A., Greene, S. M., Hodne, D., Nelson, B., Morrison, J., Domanski, M. J., Wagoner, L. E., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509937103 · Cited by 454
The role of interfacial lipids in stabilizing membrane protein oligomers
Gupta, K., Donlan, J. A. C., Hopper, J. T. S., Uzdavinys, P., Landreh, M., Struwe, W. B., Drew, D., Baldwin, A. J., Stansfeld, P. J., & Robinson, C. V. (2017) · Nature · doi:10.1038/nature20820 · Cited by 401
Selectivity determinants of GPCR–G-protein binding
Flock, T., Hauser, A. S., Lund, N., Gloriam, D. E., Balaji, S., & Babu, M. M. (2017) · Nature · doi:10.1038/nature22070 · Cited by 384
Self-citationUniversal allosteric mechanism for Gα activation by GPCRs
Flock, T., Ravarani, C. N. J., Sun, D., Venkatakrishnan, A. J., Kayikci, M., Tate, C. G., Veprintsev, D. B., & Babu, M. M. (2015) · Nature · doi:10.1038/nature14663 · Cited by 365
Self-citationPerez, J. M., Rathz, D. A., Petrashevskaya, N. N., Hahn, H. S., Wagoner, L. E., Schwartz, A., Dorn, G. W., & Liggett, S. B. (2003) · Nature Medicine · doi:10.1038/nm930 · Cited by 333
The WAVE regulatory complex links diverse receptors to the actin cytoskeleton
Chen, B., Brinkmann, K., Chen, Z., Pak, C. W., Liao, Y., Shi, S., Henry, L., Grishin, N. V., Bogdan, S., & Rosen, M. K. (2014) · Cell · doi:10.1016/j.cell.2013.11.048 · Cited by 323
Diverse activation pathways in class A GPCRs converge near the G-protein-coupling region
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Heydenreich, F. M., Flock, T., Miljus, T., Balaji, S., Bouvier, M., Veprintsev, D. B., Tate, C. G., et al. (2016) · Nature · doi:10.1038/nature19107 · Cited by 308
Self-citationThe genetic basis of variability in drug responses
Roden, D. M., & George Jr, A. L. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd705 · Cited by 292
Rask-Andersen, M., Masuram, S., & Schiöth, H. B. (2014) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-011613-135943 · Cited by 282
Giacomini, K. M., Krauss, R. M., Roden, D. M., Eichelbaum, M., Hayden, M. R., & Nakamura, Y. (2007) · Nature · doi:10.1038/446975a · Cited by 276
Masuho, I., Ostrovskaya, O., Kramer, G. M., Jones, C. D., Xie, K., & Martemyanov, K. A. (2015) · Science Signaling · doi:10.1126/scisignal.aab4068 · Cited by 265
Self-citationComparison of predicted and actual consequences of missense mutations
Miosge, L. A., Field, M. A., Sontani, Y., Cho, V., Johnson, S., Palkova, A., Balakishnan, B., Liang, R., Zhang, Y., Lyon, S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1511585112 · Cited by 222
denovo-db: a compendium of human de novo variants
Turner, T. N., Yi, Q., Krumm, N., Huddleston, J., Hoekzema, K., F. Stessman, H. A., Doebley, A.-L., Bernier, R. A., Nickerson, D. A., & Eichler, E. E. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkw865 · Cited by 221
Strategies to Discover Unexpected Targets for Drugs Active at G Protein–Coupled Receptors
Allen, J. A., & Roth, B. L. (2011) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010510-100553 · Cited by 216
Ethnic Differences in Cardiovascular Drug Response: Potential Contribution of Pharmacogenetics
Johnson, J. A. (2008) · Circulation · doi:10.1161/circulationaha.107.704023 · Cited by 212
GPCRdb: the G protein‐coupled receptor database – an introduction
Munk, C., Isberg, V, Mordalski, S., Harpsøe, K., Rataj, K., Hauser, A. S., Kolb, P., Bojarski, A. J., Vriend, G., & Gloriam, D. E. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13509 · Cited by 211
Self-citationThe c-terminus of GRK3 indicates rapid dissociation of G protein heterotrimers
Hollins, B., Kuravi, S., Digby, G. J., & Lambert, N. A. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.02.017 · Cited by 170
Patterns of genic intolerance of rare copy number variation in 59,898 human exomes
Exome Aggregation Consortium, Ruderfer, D. M., Hamamsy, T., Lek, M., Karczewski, K. J., Kavanagh, D., Samocha, K. E., Daly, M. J., MacArthur, D. G., Fromer, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3638 · Cited by 169
dbPTM 2016: 10-year anniversary of a resource for post-translational modification of proteins
Huang, K.-Y., Su, M.-G., Kao, H.-J., Hsieh, Y.-C., Jhong, J.-H., Cheng, K.-H., Huang, H.-D., & Lee, T.-Y. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv1240 · Cited by 163
Pharmacogenomic Biomarkers for Improved Drug Therapy—Recent Progress and Future Developments
Lauschke, V. M., Milani, L., & Ingelman-Sundberg, M. (2018) · The AAPS Journal · doi:10.1208/s12248-017-0161-x · Cited by 159
Gahbauer, S., & Böckmann, R. A. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00494 · Cited by 153
Applying Structure-Based Drug Design Approaches to Allosteric Modulators of GPCRs
Congreve, M., Oswald, C., & Marshall, F. H. (2017) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2017.05.010 · Cited by 123
A Pluridimensional View of Biased Agonism
Costa-Neto, C. M., Parreiras‐e‐Silva, L. T., & Bouvier, M. (2016) · Molecular Pharmacology · doi:10.1124/mol.116.105940 · Cited by 113
Monitoring G Protein Activation in Cells with BRET
Masuho, I., Martemyanov, K. A., & Lambert, N. A. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2914-6_8 · Cited by 107
Self-citationPharmacogenomic biomarkers: new tools in current and future drug therapy
Sim, S. C., & Ingelman‐Sundberg, M. (2010) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2010.11.008 · Cited by 106
Structured and disordered facets of the GPCR fold
Venkatakrishnan, A., Flock, T., Prado, D. E., Oates, M. E., Gough, J., & Babu, M. M. (2014) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2014.08.002 · Cited by 103
Self-citationGenes with monoallelic expression contribute disproportionately to genetic diversity in humans
Savova, V., Chun, S., Sohail, M., McCole, R. B., Witwicki, R. M., Gai, L., Lenz, T. L., Wu, C.-T., Sunyaev, S. R., & Gimelbrant, A. A. (2016) · Nature Genetics · doi:10.1038/ng.3493 · Cited by 76
Epistatic Selection between Coding and Regulatory Variation in Human Evolution and Disease
Lappalainen, T., Montgomery, S. B., Nica, A. C., & Dermitzakis, E. T. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.08.004 · Cited by 74
Nonenzymatic Rapid Control of GIRK Channel Function by a G Protein-Coupled Receptor Kinase
Raveh, A., Cooper, A., Guy-David, L., & Reuveny, E. (2010) · Cell · doi:10.1016/j.cell.2010.10.018 · Cited by 71
Allelic Expression of Deleterious Protein-Coding Variants across Human Tissues
Kukurba, K. R., Zhang, R., Li, X., Smith, K. S., Knowles, D. A., Tan, M. H., Piskol, R., Lek, M., Snyder, M. P., MacArthur, D. G., et al. (2014) · PLoS Genetics · doi:10.1371/journal.pgen.1004304 · Cited by 64
Dolfin, E., Guani, B., Lussiana, C., Mari, C., Restagno, G., & Revelli, A. (2011) · Journal of Assisted Reproduction and Genetics · doi:10.1007/s10815-011-9619-4 · Cited by 56
Integrating structural and mutagenesis data to elucidate GPCR ligand binding
Munk, C., Harpsøe, K., Hauser, A. S., Ísberg, V., & Gloriam, D. E. I. (2016) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2016.07.003 · Cited by 53
Self-citationPharmacogenetics of the G Protein-Coupled Receptors
Thompson, M. D., Cole, D. E. C., Capra, V., Siminovitch, K. A., Rovati, G. E., Burnham, W. M., & Rana, B. K. (2014) · Methods in molecular biology · doi:10.1007/978-1-4939-0956-8_9 · Cited by 34
Spotlight on Buprenorphine/Naloxone in the Treatment of Opioid Dependence†
Orman, J. S., & Keating, G. M. (2009) · CNS Drugs · doi:10.2165/11203740-000000000-00000 · Cited by 31
Gallion, J. M., Koire, A. M., Katsonis, P., Schönegge, A.-M., Bouvier, M., & Lichtarge, O. (2017) · Human Mutation · doi:10.1002/humu.23193 · Cited by 30
Rieck, M., Schuh, A. F. S., Altmann, V., Callegari-Jacques, S. M., Rieder, C. R. D. M., & Hutz, M. H. (2016) · The Pharmacogenomics Journal · doi:10.1038/tpj.2016.79 · Cited by 29
Genetic variants affecting equivalent protein family positions reflect human diversity
Raimondi, F., Betts, M. J., Lu, Q., Inoue, A., Gutkind, J. S., & Russell, R. B. (2017) · Scientific Reports · doi:10.1038/s41598-017-12971-7 · Cited by 14
Interpreting noncoding genetic variation in complex traits and human disease
Ward, L. D., & Kellis, M. (2012) · Nature Biotechnology · doi:10.1038/nbt.2422 · Cited by 6
Cited by
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Wootten, D., Christopoulos, A., Marti-Solano, M., Babu, M. M., & Sexton, P. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0049-3 · Cited by 724
Self-citationIlluminating G-Protein-Coupling Selectivity of GPCRs
Inoue, A., Raimondi, F., Kadji, F. M. N., Singh, G., Kishi, T., Uwamizu, A., Ono, Y., Shinjo, Y., Ishida, S., Arang, N., et al. (2019) · Cell · doi:10.1016/j.cell.2019.04.044 · Cited by 638
Common activation mechanism of class A GPCRs
Zhou, Q., Yang, D., Wu, M., Guo, Y., Guo, W., Zhong, L., Cai, X., Dai, A., Jang, W., Shakhnovich, E. I., et al. (2019) · eLife · doi:10.7554/elife.50279 · Cited by 632
Self-citationGPCRdb in 2018: adding GPCR structure models and ligands
Pándy-Szekeres, G., Munk, C., Tsonkov, T. M., Mordalski, S., Harpsøe, K., Hauser, A. S., Bojarski, A. J., & Gloriam, D. E. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1109 · Cited by 553
Self-citationGPCRdb in 2021: integrating GPCR sequence, structure and function
Kooistra, A. J., Mordalski, S., Pándy-Szekeres, G., Esguerra, M., Mamyrbekov, A., Munk, C., Keserű, G. M., & Gloriam, D. E. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkaa1080 · Cited by 351
Self-citation
Metadata
- Authors
- Hauser, A. S., Chavali, S., Masuho, I., Jahn, L. J., Martemyanov, K. A., Gloriam, D. E., & Babu, M. M.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 172
- Issue
- 1-2
- Pages
- 41-54.e19
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2774455409
- Cited by
- 616
- References
- 68
- FWCI
- 57.65
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.